A review of the pathophysiological mechanisms of doxorubicin-induced cardiotoxicity and aging
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
A review of the pathophysiological mechanisms of doxorubicin-induced cardiotoxicity and aging ; volume:10 ; number:1 ; day:23 ; month:1 ; year:2024 ; pages:1-9 ; date:12.2024
npj aging ; 10, Heft 1 (23.1.2024), 1-9, 12.2024
- Urheber
-
Linders, Annet Nicole
Dias, Itamar Braga
López Fernández, Teresa
Tocchetti, Carlo Gabriele
Bomer, Nils
Van der Meer, Peter
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41514-024-00135-7
- URN
-
urn:nbn:de:101:1-2024040309382791833051
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:53 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Linders, Annet Nicole
- Dias, Itamar Braga
- López Fernández, Teresa
- Tocchetti, Carlo Gabriele
- Bomer, Nils
- Van der Meer, Peter
- SpringerLink (Online service)
Ähnliche Objekte (12)
Rifampicin efficacy against doxorubicin-induced cardiotoxicity in mice
Diazoxide protects against doxorubicin-induced cardiotoxicity in the rat
Doxorubicin-induced cardiotoxicity in adult Indian patients on chemotherapy
Sex Differences in Doxorubicin‐Induced Cardiotoxicity: Insights from Transcriptome Analysis
Protective effect of silymarin on doxorubicin-induced cardiotoxicity in rats
Tripartite motif 25 ameliorates doxorubicin-induced cardiotoxicity by degrading p85α
The significance of the apelinergic system in doxorubicin-induced cardiotoxicity
PFKM inhibits doxorubicin-induced cardiotoxicity by enhancing oxidative phosphorylation and glycolysis
Shikonin alleviates doxorubicin-induced cardiotoxicity via Mst1/Nrf2 pathway in mice
The Role of AMPK Activation for Cardioprotection in Doxorubicin-Induced Cardiotoxicity
Cardiomyocyte-specific disruption of Cathepsin K protects against doxorubicin-induced cardiotoxicity
GAS-STING signaling plays an essential pathogenetic role in Doxorubicin-Induced Cardiotoxicity
Rifampicin efficacy against doxorubicin-induced cardiotoxicity in mice
Diazoxide protects against doxorubicin-induced cardiotoxicity in the rat
Doxorubicin-induced cardiotoxicity in adult Indian patients on chemotherapy
Sex Differences in Doxorubicin‐Induced Cardiotoxicity: Insights from Transcriptome Analysis
Protective effect of silymarin on doxorubicin-induced cardiotoxicity in rats
Tripartite motif 25 ameliorates doxorubicin-induced cardiotoxicity by degrading p85α
The significance of the apelinergic system in doxorubicin-induced cardiotoxicity
PFKM inhibits doxorubicin-induced cardiotoxicity by enhancing oxidative phosphorylation and glycolysis
Shikonin alleviates doxorubicin-induced cardiotoxicity via Mst1/Nrf2 pathway in mice
The Role of AMPK Activation for Cardioprotection in Doxorubicin-Induced Cardiotoxicity
Cardiomyocyte-specific disruption of Cathepsin K protects against doxorubicin-induced cardiotoxicity
GAS-STING signaling plays an essential pathogenetic role in Doxorubicin-Induced Cardiotoxicity
Rifampicin efficacy against doxorubicin-induced cardiotoxicity in mice
Diazoxide protects against doxorubicin-induced cardiotoxicity in the rat
Doxorubicin-induced cardiotoxicity in adult Indian patients on chemotherapy
Sex Differences in Doxorubicin‐Induced Cardiotoxicity: Insights from Transcriptome Analysis
Protective effect of silymarin on doxorubicin-induced cardiotoxicity in rats
Tripartite motif 25 ameliorates doxorubicin-induced cardiotoxicity by degrading p85α
The significance of the apelinergic system in doxorubicin-induced cardiotoxicity
PFKM inhibits doxorubicin-induced cardiotoxicity by enhancing oxidative phosphorylation and glycolysis
Shikonin alleviates doxorubicin-induced cardiotoxicity via Mst1/Nrf2 pathway in mice
The Role of AMPK Activation for Cardioprotection in Doxorubicin-Induced Cardiotoxicity
Cardiomyocyte-specific disruption of Cathepsin K protects against doxorubicin-induced cardiotoxicity